Please use this identifier to cite or link to this item:
|Title:||Advances in Neutrophil Testing In Type 2 Diabetes Mellitus||Authors:||Tay, Hui Min
Hou, Han Wei
Boehm, Bernhard Otto
|Issue Date:||2017||Source:||Hou, H. W., Tay, H. M., Dalan, R., & Boehm, B. O. (2017). Advances in Neutrophil Testing In Type 2 Diabetes Mellitus. Current Research in Diabetes & Obesity Journal, 1(5), 555572-.||Series/Report no.:||Current Research in Diabetes & Obesity Journal||Abstract:||Patients with type 2 diabetes mellitus (T2DM) suffer from impaired glucose metabolism which results in low-grade inflammation and activation of the innate immune system. Neutrophils the key effector cells of the innate immune system and heavily implicated in the pathogenesis of T2DM, are promising cell-based inflammatory biomarkers for immune health profiling, provided that they can be rapidly purified and measured with sufficient precision. In this review, we highlight recent advances in neutrophil isolation and functional assay using microfluidics technologies and the potential of their functional phenotype as a novel biomarker of vascular risk in diabetes.||URI:||https://hdl.handle.net/10356/83026
|ISSN:||2476-1435||Rights:||This work is licensed under Creative Commons Attribution 4.0 License||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||LKCMedicine Journal Articles|
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.